Strategic policy engagement that advances sustainable access to healthcare.
Through our Public & Policy Affairs services, we help pharmaceutical partners understand and navigate increasingly complex healthcare environments. Combining deep local insight, regional coordination, and transparent stakeholder engagement, we support constructive policy dialogue and evidence-based solutions that contribute to sustainable patient access to medicines.
Identifying relevant stakeholders and supporting transparent, evidence-based engagement with ministries, payers, health authorities, public institutions and healthcare decision-makers.
Developing market-specific and multi-country strategies aligned with partners’ business priorities, product lifecycles, Market Access objectives and patient needs.
Developing advocacy initiatives, multi-stakeholder partnerships and effective industry association engagement around shared healthcare priorities, unmet needs and access to innovative therapies.
Developing clear, evidence-based narratives, briefing materials, policy positions and stakeholder communications for local and regional audiences.
Connecting Market Access, Medical, Regulatory, Commercial and Communications capabilities from policy insight and strategy through local implementation.
Monitoring political, legislative and healthcare policy developments, assessing their impact, and identifying emerging risks and opportunities to inform strategic recommendations and coordinated responses.
Local Expertise, Regional Reach, and Integrated Execution.
National policy insight aligned across multiple markets
Policy expertise integrated with Market Access, Medical, Regulatory and Commercial capabilities
Transparent engagement aligned with legislation, industry codes and partner standards
Flexible support tailored to partner priorities and operating models
Policy solutions connecting healthcare needs with sustainable patient access
Our Policy & Public Affairs services combine an in-depth understanding of local healthcare systems with coordinated regional capabilities across EL PHARMA markets.
With extensive track of records in successfully serving partners across pharmaceutical industry, we are committed to bridging the healthcare gap across Europe.